[논문]Anxiety and depression in spasmodic dysphonia patients

Hu, Amanda; Hillel, Al; Zhao, Wei; Meyer, Tanya

doi:10.1016/j.wjorl.2018.04.004

Anxiety and depression in spasmodic dysphonia patients 원문보기

World journal of otorhinolaryngology-head and neck surgery, v.4 no.2, 2018년, pp.110 - 116

Hu, Amanda (Division of Otolaryngology –) , Hillel, Al (Head & Neck Surgery, Department of Surgery, University of British Columbia, Vancouver, Canada) , Zhao, Wei (Department of Otolaryngology –) , Meyer, Tanya (Head & Neck Surgery, University of Washington, Seattle, WA, USA)

Abstract ▼ AI-Helper

Objective/HypothesisExperts used to believe that spasmodic dysphonia (SD) was a psychogenic disorder. Although SD is now established as a neurological disorder, the rates of co-morbid anxiety and depression range from 7.1% to 62%. Our objective was to study the prevalence and risk factors associated with these mood disorders in SD patients.Study designRetrospective.MethodsSD patients who presented for botulinum toxin injections were recruited. Demographic data, Hospital Anxiety and Depression Scale (HADS), Voice Handicap Index-10 (VHI-10), General Self-Efficacy scale (GSES), Disease Specific Self-Efficacy in Spasmodic Dysphonia scale (DSSE), and Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) were collected.ResultsOne hundred and forty two patients (age (59.2 ± 13.6) years, 25.4% male) had VHI-10 of 26.3 ± 6.9 (mean ± standard deviation), GSES 33.2 ± 5.8, CAPE-V 43.9 ± 20.9, HADS anxiety 6.7 ± 3.7, and HADS depression 3.6 ± 2.8. About 19 (13.4%) and 4 (2.8%) had symptoms of anxiety and depression respectively. Final linear regression model for HADS anxiety (R2 = 32.90%) showed that patients who were less likely to have anxiety symptoms were older age (p < 0.001), male (p = 0.002), have higher GSES (p < 0.001) and lower VHI-10 (p = 0.004). Final linear regression model for HADS depression score (R2 = 34.42%) showed that patients who were less likely to have depressive symptoms had high DSSES (p < 0.001).ConclusionsPrevalence of anxiety (13.4%) and depression (2.8%) in SD were lower than previously reported in the literature. Risk factors for anxiety were: younger age, female gender, lower general self-efficacy, and higher perceived vocal handicap. The main risk factor for depression was lower disease specific self-efficacy.

참고문헌 (37)

1 Traube L. Gesammelte Beitr€age zur Pathologie und Physiologie 1871 I, II. Berlin, Germany: August Hirschwald
2 Murry T. Spasmodic dysphonia: let's look at that again J Voice 28 2014 694 699 24972536

상세보기
3 White L.J. Hapner E.R. Klein A.M. Coprevalence of anxiety and depression with spasmodic dysphonia: a case-control study J Voice 26 2012 667.e1-6

상세보기
4 Moore G.P. Organic Voice Disorders 1971 Prentice Hall, Inc Englewood Cliffs, NJ 9 10
5 National Spasmodic Dysphonia Association What Is Spasmodicdysphonia? 2016 http://www.dysphonia.org/spasmodic-dysphonia.php
6 Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series Eur J Neurol 17 Suppl 1 2010 28 30 20590805
7 Asgeirsson H. Jakobsson F. Hjaltason H. Jonsdottir H. Sveinbjornsdottir S. Prevalence study of primary dystoniain Iceland Mov Disord 21 2006 293 298 16211610
8 Nerurkar N.K. Banu T.P. Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population J Laryngol Otol 128 2014 649 653 24999662

상세보기
9 Liu C.Y. Yu J.M. Wang N.M. Emotional symptoms are secondary to the voice disorder in patients with spasmodic dysphonia Gen Hosp Psychiatry 20 1998 255 259 9719906
10 Mirza N. Ruiz C. Baum E.D. Staab J.P. The prevalence of major psychiatric pathologies in patients with voice disorders Ear Nose Throat J 82 2003 808 810 812, 814 14606179

상세보기
11 Aronson A.E. Brown J.R. Litin E.M. Pearson J.S. Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias J Speech Hear Disord 33 1968 219 231 5668051

상세보기
12 Zigmond A.S. Snaith R.P. The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370 6880820

상세보기
13 Rosen C.A. Lee A.S. Osborne J. Zullo T. Murry T. Development and validation of the voice handicap index-10 Laryngoscope 114 2004 1549 1556 15475780

상세보기
14 Schwarzer R. Jerusalem M. Weinman J. GeneralizedSelf-efficacy Scale. Measures in Health Psychology: A UsersPortfolio. Causal and Control Beliefs 1995 NFERNELSON Windsor
15 The American Speech-Language-Hearing Association (ASHA)Special Interest Division 3 Voice and Voice Disorders. ConsensusAuditory-perceptual Evaluation of Voice (CAPE-v) 2002 http://www.asha.org/uploadedFiles/members/divs/D3CAPEVprocedures.pdf
16 Bjelland I. Dahl A.A. Haug T.T. Neckelmann D. The validity of the Hospital Anxiety and Depression Scale—anupdated literature review J Psychosom Res 52 2002 69 77 11832252

상세보기
17 Dietrich M. Verdolini Abbott K. Gartner-Schmidt J. Rosen C.A. The frequency of perceived stress, anxiety, and depression in patients with commonpathologies affecting voice J Voice 22 2008 472 488 18395419

상세보기
18 Millar A. Deary I.J. Wilson J.A. MacKenzie K. Is an organic/functional distinction psychologically meaningful in patients with dysphonia J Psychosom Res 46 1999 497 505 10454164

상세보기
19 Deary I.J. Scott S. Wilson I.M. White A. MacKenzie K. Wilson J.A. Personality and psychological distress indysphonia Br J Health Psychol 2 1997 333 341
20 Bandura A. Self-efficacy: The Exercise of Control 1997 Freeman New York
21 Borrelli B. Hogan J.W. Bock B. Pinto B. Roberts M. Marcus B. Predictors of quitting and dropout among women in a clinic based smoking cessation program Psychol Addict Behav 16 2002 22 27 11934082

상세보기
22 Mishalia M. Omera H. Heymann A.D. The importance of measuring self-efficacy in patients with diabetes Fam Pract 28 2011 82 87 21047940

상세보기
23 Gillespie A.I. Abbott K.V. The influence of clinical terminology on self-efficacy for voice Logoped Phoniatr Vocol 36 3 2011 91 99 21182367

상세보기
24 Wong ML. Relationship between voice self-efficacy and voice related disability. http://hdl.handle.net/10722/1238842008 . Accessed July 26, 2012.
25 Ornstein A.F. Manning W.H. Self-efficacy scaling by adult stutterers J Commun Disord 18 1985 313 320 4019820

상세보기
26 Hu A. Isetti D. Hillel A.D. Disease-specific self-efficacy in spasmodic dysphonia patients Otolaryngol Head Neck Surg 148 2013 450 455 23300221
27 Schwarzer R. Everything You Wanted to Know about Self efficacy but Were Afraid to Ask May 30, 2011 http://www.ralfschwarzer.de
28 Gündel H. Busch R. Ceballos-Baumann A. Seifert E. Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study J Neurol Neurosurg Psychiatry 78 2007 1398 1400 17615166

상세보기
29 National Institutes of Health Major Depression Among Adults 2014 Available at: http://www.nimh.nih.gov/health/statistics/prevalence/major-depression-among-adults.shtml
30 National Institutes of Health Any Anxiety Disorder Among Adults 2014 Available at: http://www.nimh.nih.gov/health/statistics/prevalence/any-anxiety-disorder-among-adults.shtml
31 Scott K.M. Von Korff M. Alonso M. Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical comorbidity Psychol Med 38 2008 1659 1669 18485262

상세보기
32 Stewart C.F. Allen E.L. Tureen P. Adductor spasmodic dysphonia: standard evaluation of symptoms and severity J Voice 11 1997 95 103 9075182

상세보기
33 Henrich G. Herschbach P. Questions on life satisfaction (FLZ)—a short questionnaire for assessing subjective quality of life Eur J Psychol Assess 16 2000 150 159
34 Takaki J. Nishi T. Shimoyama H. Interactions among a stressor, self-efficacy, coping with stress, depression, and anxiety in maintenance hemodialysis patients Behav Med 29 3 2003 107 112 15206829

상세보기
35 Robertson S.M. Amspoker A.B. Cully J.A. Ross E.L. Naik A.D. Affective symptoms and change in diabetes self-efficacy and glycaemic control Diabet Med 30 2013 e189 e196 23350920

상세보기
36 Garnefski N. Kraaij V. Benoist M. Effect of a cognitive behavioral self-help intervention on depression, anxiety, and coping self-efficacy in people with rheumatic disease Arthritis Care Res (Hoboken) 65 2013 1077 1084 23281332

상세보기
37 Wernand J.J. Kunseler F.C. Oosterman M. Beekman A.T. Schuengel C. Prenatal changes in parenting self-efficacy: linkages with anxiety and depressive symptoms in primiparous women Infant Ment Health J 35 2014 42 50 25424405

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Anxiety and depression in spasmodic dysphonia patients 원문보기

Abstract ▼ AI-Helper

참고문헌 (37)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트